Equities

Innova Captab Ltd

INNOVACAP:NSI

Innova Captab Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)794.90
  • Today's Change21.90 / 2.83%
  • Shares traded86.71k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Innova Captab Ltd grew revenues 16.72% from 9.26bn to 10.81bn while net income improved 38.84% from 679.54m to 943.45m.
Gross margin33.38%
Net profit margin9.30%
Operating margin12.90%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, Innova Captab Ltd increased its cash reserves by 232.71%, or 82.03m. Cash Flow from Financing totalled 3.61bn or 33.37% of revenues. In addition the company generated 1.46bn in cash from operations while cash used for investing totalled 4.99bn.
Cash flow per share25.74
Price/Cash flow per share35.64
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Innova Captab Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 31.80%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)35.13
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.